# The Luteal Phase After GnRHa Trigger - a Proof of Concept Study

> **NCT01504139** · PHASE4 · COMPLETED · sponsor: **Regionshospitalet Viborg, Skive** · enrollment: 93 (actual)

## Conditions studied

- Progesterone Levels
- Infertility

## Interventions

- **DRUG:** hCG(r-hCG, Ovitrelle, Merck-Serono, Hellerup, Denmark) in the late follicular phase + luteal phase
- **DRUG:** hCG(r-hCG, Ovitrelle,Merck-Serono, Hellerup, Denmark) in the follicular phase + luteal phase
- **DRUG:** LH(r-LH,Luveris, Merck-Serono, Hellerup, Denmark) in the luteal phase
- **DRUG:** vaginal progesterone(Crinone; Merck-Serono, Hellerup, Denmark) and estradiol(Estrofem; Novo Nordisk, Copenhagen, Denmark) in the luteal phase

## Key facts

- **NCT ID:** NCT01504139
- **Lead sponsor:** Regionshospitalet Viborg, Skive
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2014-04
- **Final completion:** 2014-08
- **Target enrollment:** 93 (ACTUAL)
- **Last updated:** 2015-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01504139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01504139, "The Luteal Phase After GnRHa Trigger - a Proof of Concept Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01504139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*